Moderna Total Assets 2017-2020 | MRNA

Moderna total assets from 2017 to 2020. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • Moderna total assets for the quarter ending June 30, 2020 were $3.486B, a 106.85% increase year-over-year.
  • Moderna total assets for 2019 were $1.589B, a 19% decline from 2018.
  • Moderna total assets for 2018 were $1.962B, a 80.93% increase from 2017.
  • Moderna total assets for 2017 were $1.084B, a 23.47% decline from 2016.
Moderna Annual Total Assets
(Millions of US $)
2019 $1,589
2018 $1,962
2017 $1,084
2016 $1,417
Moderna Quarterly Total Assets
(Millions of US $)
2020-06-30 $3,486
2020-03-31 $2,068
2019-12-31 $1,589
2019-09-30 $1,591
2019-06-30 $1,685
2019-03-31 $1,806
2018-12-31 $1,962
2018-09-30 $0
2018-06-30 $0
2018-03-31 $0
2017-12-31 $1,084
2016-12-31 $1,417
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $27.286B $0.060B
Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA- 2752 for Relapsed/Refractory solid tumors malignancies. Moderna Inc. is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $142.912B 11.00
Amgen (AMGN) United States $140.397B 15.25
CSL (CSLLY) Australia $90.637B 0.00
Gilead Sciences (GILD) United States $85.880B 12.36
Vertex Pharmaceuticals (VRTX) United States $69.620B 38.85
Regeneron Pharmaceuticals (REGN) United States $67.394B 24.92
Illumina (ILMN) United States $51.091B 59.01
Biogen (BIIB) United States $45.824B 7.84
Seattle Genetics (SGEN) United States $27.365B 0.00
Genmab (GMAB) Denmark $24.126B 15.26
Alexion Pharmaceuticals (ALXN) United States $22.568B 9.40
Genmab (GNMSF) Denmark $22.519B 5.19
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $22.470B 0.00
BioMarin Pharmaceutical (BMRN) United States $21.428B 155.47
Incyte (INCY) United States $20.748B 0.00
BeiGene (BGNE) Cayman Islands $18.829B 0.00
Alnylam Pharmaceuticals (ALNY) United States $15.788B 0.00
BioNTech SE (BNTX) Germany $15.531B 0.00
Bio-Rad Laboratories (BIO.B) United States $15.036B 68.01
Horizon Therapeutics Public (HZNP) Ireland $15.034B 35.18
Exact Sciences (EXAS) United States $12.814B 0.00
Sarepta Therapeutics (SRPT) United States $12.325B 0.00
Galapagos (GLPG) Belgium $12.168B 44.09
QIAGEN (QGEN) Netherlands $11.262B 28.58
ARGENX SE-ADR (ARGX) Netherlands $11.035B 0.00
Bio-Techne Corp (TECH) United States $9.977B 69.06
Immunomedics (IMMU) United States $9.246B 0.00
Novavax (NVAX) United States $8.978B 0.00
Guardant Health (GH) United States $8.497B 0.00
Repligen (RGEN) United States $7.555B 119.91
Ascendis Pharma (ASND) Denmark $7.527B 0.00
Emergent Biosolutions (EBS) United States $7.061B 27.97
Exelixis (EXEL) United States $6.792B 24.70
Vir Biotechnology (VIR) United States $6.701B 0.00
SWEDISH ORP BIO (BIOVF) Sweden $6.600B 16.42
CRISPR Therapeutics AG (CRSP) Switzerland $6.280B 194.57
ACADIA Pharmaceuticals (ACAD) United States $6.205B 0.00
Mirati Therapeutics (MRTX) United States $6.180B 0.00
Acceleron Pharma (XLRN) United States $5.481B 0.00
Adaptive Biotechnologies (ADPT) United States $5.337B 0.00
MyoKardia (MYOK) United States $5.260B 0.00
Ultragenyx Pharmaceutical (RARE) United States $5.157B 0.00
Zai Lab (ZLAB) China $4.621B 0.00
NeoGenomics (NEO) United States $4.299B 1297.67
China Biologic Products (CBPO) China $4.253B 23.64
MorphoSys AG (MOR) Germany $4.181B 54.79
Blueprint Medicines (BPMC) United States $4.088B 0.00
Bluebird Bio (BLUE) United States $3.952B 0.00
Halozyme Therapeutics (HALO) United States $3.822B 0.00
Global Blood Therapeutics (GBT) United States $3.776B 0.00
Amicus Therapeutics (FOLD) United States $3.727B 0.00
Arena Pharmaceuticals (ARNA) United States $3.666B 0.00
Momenta Pharmaceuticals (MNTA) United States $3.463B 0.00
Reata Pharmaceuticals (RETA) United States $3.397B 0.00
Denali Therapeutics (DNLI) United States $3.247B 0.00
Principia Biopharma (PRNB) United States $3.013B 0.00
Sorrento Therapeutics (SRNE) United States $3.011B 0.00
Fate Therapeutics (FATE) United States $2.988B 0.00
Twist Bioscience (TWST) United States $2.961B 0.00
Alkermes (ALKS) Ireland $2.952B 61.87
Insmed (INSM) United States $2.701B 0.00
Amarin (AMRN) Ireland $2.644B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.552B 0.00
Inovio Pharmaceuticals (INO) United States $2.477B 0.00
Editas Medicine (EDIT) United States $2.174B 0.00
Mesoblast (MESO) Australia $2.088B 0.00
Seres Therapeutics (MCRB) United States $2.079B 0.00
Viela Bio (VIE) United States $1.977B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $1.926B 45.83
Ligand Pharmaceuticals (LGND) United States $1.821B 61.55
UniQure (QURE) Netherlands $1.817B 0.00
PHARMA MAR SA (PHMMF) Spain $1.797B 0.00
I-Mab (IMAB) China $1.706B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.642B 0.00
Sangamo Therapeutics (SGMO) United States $1.606B 0.00
Eidos Therapeutics (EIDX) United States $1.595B 0.00
Cytokineticsorporated (CYTK) United States $1.588B 0.00
Revance Therapeutics (RVNC) United States $1.588B 0.00
Arcus Biosciences (RCUS) United States $1.543B 0.00
Zealand Pharma (ZEAL) Denmark $1.539B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.415B 0.00
Coherus BioSciences (CHRS) United States $1.363B 7.95
Zymeworks (ZYME) Canada $1.346B 0.00
Intra-Cellular Therapies (ITCI) United States $1.302B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.285B 0.00
Epizyme (EPZM) United States $1.282B 0.00
Zealand Pharma (ZLDPF) Denmark $1.276B 0.00
Mersana Therapeutics (MRSN) United States $1.271B 0.00
NGM Biopharmaceuticals (NGM) United States $1.191B 0.00
REGENXBIO (RGNX) United States $1.182B 0.00
Compugen (CGEN) Israel $1.177B 0.00
Alcobra (ARCT) United States $1.176B 0.00
Intellia Therapeutics (NTLA) United States $1.168B 0.00
Beam Therapeutics (BEAM) United States $1.163B 0.00
Akcea Therapeutics (AKCA) United States $1.120B 0.00
Adverum Biotechnologies (ADVM) United States $1.072B 0.00
Alector (ALEC) United States $1.066B 0.00
Arvinas (ARVN) United States $1.047B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.042B 0.00
Heska (HSKA) United States $0.999B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $0.965B 0.00
NantKwest (NK) United States $0.956B 0.00
Myriad Genetics (MYGN) United States $0.944B 0.00
Retrophin (RTRX) United States $0.933B 0.00
Athenex (ATNX) United States $0.911B 0.00
VBI Vaccines (VBIV) United States $0.842B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.835B 0.00
Castle Biosciences (CSTL) United States $0.813B 0.00
Pharming Group (PHGUF) Netherlands $0.801B 18.29
Morphic Holding (MORF) United States $0.799B 0.00
Codexis (CDXS) United States $0.787B 0.00
Intrexon (PGEN) United States $0.767B 0.00
Cara Therapeutics (CARA) United States $0.764B 0.00
Frequency Therapeutics (FREQ) United States $0.736B 0.00
Dynavax Technologies (DVAX) United States $0.736B 0.00
Cellectis S.A (CLLS) France $0.727B 0.00
MiMedx (MDXG) United States $0.725B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.720B 0.00
Kadmon Holdings (KDMN) United States $0.707B 0.00
Vericel (VCEL) United States $0.695B 0.00
Agenus (AGEN) United States $0.681B 0.00
Sinovac Biotech (SVA) China $0.640B 20.87
Vanda Pharmaceuticals (VNDA) United States $0.638B 5.58
ZIOPHARM Oncology Inc (ZIOP) United States $0.632B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.610B 0.00
Cue Biopharma (CUE) United States $0.600B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Protagonist Therapeutics (PTGX) United States $0.578B 0.00
Syros Pharmaceuticals (SYRS) United States $0.545B 0.00
MeiraGTx Holdings (MGTX) United States $0.526B 0.00
BioDelivery Sciences (BDSI) United States $0.518B 36.68
Aquinox Pharmaceuticals (NLTX) United States $0.513B 0.00
Geron (GERN) United States $0.509B 0.00
Anika Therapeutics (ANIK) United States $0.508B 22.22
Innate Pharma S.A (IPHA) France $0.501B 0.00
Prothena (PRTA) Ireland $0.492B 0.00
Kala Pharmaceuticals (KALA) United States $0.492B 0.00
Cel-Sci (CVM) United States $0.491B 0.00
Avid Bioservices (CDMO) United States $0.480B 0.00
Athersys (ATHX) United States $0.480B 0.00
UROGEN PHARMA (URGN) United States $0.480B 0.00
AC Immune SA (ACIU) Switzerland $0.463B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.463B 0.00
AnaptysBio (ANAB) United States $0.462B 0.00
Kamada (KMDA) Israel $0.443B 21.17
Pfenex (PFNX) United States $0.438B 0.00
IVERIC Bio (ISEE) United States $0.428B 0.00
Clovis Oncology (CLVS) United States $0.425B 0.00
Celldex Therapeutics (CLDX) United States $0.403B 0.00
Prometic Life Sciences (LMNL) Canada $0.399B 0.00
ANI Pharmaceuticals (ANIP) United States $0.399B 9.42
Scholar Rock Holding (SRRK) United States $0.398B 0.00
Puma Biotechnology (PBYI) United States $0.390B 0.00
PDL BioPharma (PDLI) United States $0.381B 0.00
Albireo Pharma (ALBO) United States $0.380B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.379B 0.00
Merus (MRUS) Netherlands $0.374B 0.00
MannKind (MNKD) United States $0.369B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.362B 0.00
Biofrontera AG (BFRA) Germany $0.361B 0.00
Cellular Biomedicine (CBMG) United States $0.360B 0.00
WAVE Life Sciences (WVE) Singapore $0.332B 0.00
Precision BioSciences (DTIL) United States $0.319B 0.00
OSMOTICA PHARM (OSMT) United States $0.317B 0.00
CytomX Therapeutics (CTMX) United States $0.317B 0.00
IBio (IBIO) United States $0.308B 0.00
Trevena (TRVN) United States $0.307B 0.00
Sutro Biopharma (STRO) United States $0.306B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.302B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.297B 0.00
ChromaDex (CDXC) United States $0.296B 0.00
Arbutus Biopharma (ABUS) United States $0.281B 0.00
Fortress Biotech (FBIO) United States $0.277B 0.00
Selecta Biosciences (SELB) United States $0.275B 0.00
Starpharma Holdings (SPHRY) Australia $0.275B 0.00
Menlo Therapeutics (MNLO) United States $0.270B 0.00
ADMA Biologics Inc (ADMA) United States $0.269B 0.00
Spero Therapeutics (SPRO) United States $0.264B 0.00
Affimed (AFMD) Germany $0.262B 0.00
DBV Technologies S.A (DBVT) France $0.257B 0.00
NextCure (NXTC) United States $0.251B 0.00
Verastem (VSTM) United States $0.249B 0.00
Forte Biosciences (FBRX) United States $0.239B 0.00
Northwest Biotherapeutics (NWBO) United States $0.237B 0.00
Abeona Therapeutics (ABEO) United States $0.233B 0.00
HOOKIPA Pharma (HOOK) United States $0.222B 0.00
Pluristem Therapeutics (PSTI) Israel $0.222B 0.00
Liquidia Technologies (LQDA) United States $0.215B 0.00
XOMA (XOMA) United States $0.213B 0.00
Dyadic (DYAI) United States $0.210B 0.00
Theratechnologies (THTX) Canada $0.208B 0.00
Exicure (XCUR) United States $0.201B 0.00
Strongbridge Biopharma (SBBP) United States $0.201B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.195B 0.00
Aduro Biotech (ADRO) United States $0.195B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.194B 9.05
Nymox Pharmaceutical (NYMX) Canada $0.193B 0.00
Cerecor (CERC) United States $0.192B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Five Prime Therapeutics (FPRX) United States $0.185B 0.00
Cyclerion Therapeutics (CYCN) United States $0.176B 0.00
Aptinyx (APTX) United States $0.175B 0.00
VTv Therapeutics (VTVT) United States $0.173B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.160B 0.00
Kindred Biosciences (KIN) United States $0.159B 0.00
Cidara Therapeutics (CDTX) United States $0.157B 0.00
Aytu Bioscience (AYTU) United States $0.156B 0.00
Bellus Health (BLU) Canada $0.153B 0.00
TELA Bio (TELA) United States $0.150B 0.00
Applied Genetic Technologies (AGTC) United States $0.149B 0.00
Eton Pharmaceuticals (ETON) United States $0.148B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Celyad SA (CYAD) Belgium $0.144B 0.00
VolitionRX (VNRX) United States $0.143B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.138B 0.00
CorMedix Inc (CRMD) United States $0.136B 0.00
Cardiff Oncology (CRDF) United States $0.135B 0.00
Gritstone Oncology (GRTS) United States $0.134B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.131B 0.00
Palatin Technologies (PTN) United States $0.130B 3.32
Oncobiologics (OTLK) United States $0.128B 0.00
Orgenesis (ORGS) United States $0.125B 6.38
Lumos Pharma (LUMO) United States $0.124B 0.00
Checkpoint Therapeutics (CKPT) United States $0.124B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.124B 0.00
SESEN BIO, INC (SESN) United States $0.123B 0.00
Protalix BioTherapeutics (PLX) Israel $0.120B 0.00
Enzo Biochem (ENZ) United States $0.120B 0.00
PHASEBIO PHARMA (PHAS) United States $0.118B 0.00
Catalyst Biosciences (CBIO) United States $0.117B 0.00
Windtree Therapeutics (WINT) United States $0.116B 0.00
ARAVIVE, INC (ARAV) United States $0.103B 0.00
Vaccinex (VCNX) United States $0.102B 0.00
Cocrystal Pharma (COCP) United States $0.100B 0.00
Antibe Therapeutics (ATBPF) Canada $0.097B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
Organovo Holdings (ONVO) United States $0.092B 0.00
Unum Therapeutics (UMRX) United States $0.090B 0.00
Synlogic (SYBX) United States $0.086B 0.00
Clearside Biomedical (CLSD) United States $0.083B 0.00
AquaBounty Technologies (AQB) United States $0.082B 0.00
AnPac Bio-Medical Science (ANPC) China $0.081B 0.00
Emmaus Life Sciences (EMMA) United States $0.080B 0.00
Adocia (ADOCY) France $0.080B 0.00
Ecology Coatings (ABVC) United States $0.077B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
DiaMedica Therapeutics (DMAC) United States $0.076B 0.00
Proteostasis Therapeutics (PTI) United States $0.071B 0.00
Idera Pharmaceuticals (IDRA) United States $0.070B 0.00
Curis (CRIS) United States $0.069B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.067B 0.00
Edesa Biotech (EDSA) Canada $0.066B 0.00
Stealth BioTherapeutics (MITO) United States $0.063B 90.50
ANIXA BIOSCIENCES INC (ANIX) United States $0.063B 0.00
IMMURON (IMRN) Australia $0.062B 0.00
Signal Genetics (MGEN) United States $0.062B 0.00
Bionano Genomics (BNGO) United States $0.059B 0.00
Soligenix (SNGX) United States $0.059B 0.00
Happiness Biotech Group (HAPP) China $0.058B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.057B 0.00
Vascular Biogenics (VBLT) Israel $0.054B 0.00
Genetic Technologies (GENE) Australia $0.053B 0.00
CollPlant Holdings (CLGN) Israel $0.052B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.052B 0.00
Prima BioMed (IMMP) Australia $0.050B 0.00
Apricus Biosciences (SEEL) United States $0.046B 0.00
Novogen (KZIA) Australia $0.043B 0.00
Pulmatrix (PULM) United States $0.040B 0.00
AmpliPhi Biosciences (ARMP) United States $0.038B 0.00
Prana Biotechnology (ATHE) Australia $0.038B 0.00
Celsion (CLSN) United States $0.036B 0.00
Evogene (EVGN) Israel $0.036B 0.00
ATyr Pharma (LIFE) United States $0.036B 0.00
OvaScience (MLND) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.033B 0.00
Advaxis (ADXS) United States $0.032B 0.00
Acorda Therapeutics (ACOR) United States $0.032B 0.00
Spherix (AIKI) United States $0.031B 0.00
Alimera Sciences (ALIM) United States $0.031B 0.00
Cesca Therapeutics (THMO) United States $0.030B 0.00
Cleveland BioLabs (CBLI) United States $0.028B 0.00
AEterna Zentaris (AEZS) United States $0.027B 0.00
Titan Pharmaceuticals (TTNP) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.026B 0.00
Chanticleer Holdings (SONN) United States $0.025B 0.00
BioPharmX (TMBR) United States $0.022B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.022B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
MYOS RENS Technology (MYOS) United States $0.018B 0.00
BioCardia (BCDA) United States $0.016B 0.00
TRACON Pharmaceuticals (TCON) United States $0.015B 0.00
Neuralstem (SNCA) United States $0.012B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00